Neuromuscular Effects of Acetylcholine

Introduction to Acetylcholine Effects

Acetylcholine accumulation at nicotinic receptors in the neuromuscular junction can lead to muscle twitching, followed by weakness and potentially flaccid paralysis, as well as involuntary fasciculations (twitches) of skeletal muscles 1
Muscarinic effects of acetylcholine are associated with increased secretions, GI hypermotility, and urinary incontinence 1

Pyridostigmine works by inhibiting acetylcholinesterase in the synaptic cleft, preventing the breakdown of acetylcholine, increasing acetylcholine concentration at the neuromuscular junction, and enhancing neuromuscular transmission through prolonged activation of nicotinic receptors, similar to organophosphate pesticides and chemical nerve agents 2

Muscle twitching is a common side effect of pyridostigmine, particularly at doses of 150mg or higher, and may be poorly tolerated in patients with cardiac involvement or restrictive physiology, according to the American College of Cardiology 3
Approximately 91% of patients experience some muscle twitching at a dose of 150mg of pyridostigmine, representing the unopposed actions of acetylcholine on nicotinic receptors 3, 2

Dose adjustment (reducing to <150mg) may be considered if muscle twitching becomes problematic, to reduce the risk of cholinergic side effects, as recommended by the American College of Cardiology 3
Spreading doses more evenly throughout the day may help alleviate muscle twitches, according to clinical guidelines 4
The American College of Clinical Pharmacology recommends considering dose adjustment, typically 30-120 mg PO three to four times daily, if muscle twitches are bothersome in patients taking pyridostigmine 4

Monitoring severity, considering dose adjustment, and evaluating for cholinergic crisis are recommended for patients experiencing muscle twitching while on pyridostigmine 2
Assessing if twitches are part of a broader cholinergic crisis requiring immediate intervention, and distinguishing between beneficial effects and adverse effects of the medication, is crucial in patients taking pyridostigmine, as suggested by the National Institute of Neurological Disorders and Stroke 4

Pyridostigmine is recommended as the first-line treatment for myasthenia gravis by the American Academy of Ophthalmology, despite muscle twitching being a potential side effect 5
For patients with myasthenia gravis, some degree of muscle twitching may be acceptable if the overall control of myasthenic symptoms is good, as noted by the Myasthenia Gravis Foundation of America 4
Guidelines recommend using a reduced dose of a neuromuscular blocking agent (NMBA) for patients with myasthenia gravis, with the dose based on peripheral nerve stimulation (PNS) with train-of-four (TOF) monitoring 2